Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Fulgent Genetics Inc (FLGT)

Fulgent Genetics Inc (FLGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 838,952
  • Shares Outstanding, K 30,912
  • Annual Sales, $ 283,470 K
  • Annual Income, $ -42,710 K
  • EBIT $ -63 M
  • EBITDA $ -44 M
  • 60-Month Beta 0.65
  • Price/Sales 2.95
  • Price/Cash Flow N/A
  • Price/Book 0.74

Options Overview Details

View History
  • Implied Volatility 60.90% (+3.54%)
  • Historical Volatility 56.12%
  • IV Percentile 85%
  • IV Rank 57.36%
  • IV High 83.35% on 02/07/25
  • IV Low 30.69% on 09/02/25
  • Expected Move (DTE 5) 3.30 (12.15%)
  • Put/Call Vol Ratio 0.01
  • Today's Volume 127
  • Volume Avg (30-Day) 131
  • Put/Call OI Ratio 0.17
  • Today's Open Interest 4,556
  • Open Int (30-Day) 4,518
  • Expected Range 23.84 to 30.44

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.42
  • Number of Estimates 2
  • High Estimate -0.34
  • Low Estimate -0.49
  • Prior Year -0.23
  • Growth Rate Est. (year over year) -82.61%

Price Performance

See More
Period Period Low Period High Performance
1-Month
26.69 +1.69%
on 12/11/25
31.04 -12.56%
on 11/25/25
-1.94 (-6.67%)
since 11/12/25
3-Month
21.35 +27.12%
on 09/24/25
31.04 -12.56%
on 11/25/25
+5.26 (+24.04%)
since 09/12/25
52-Week
14.57 +86.27%
on 03/04/25
31.04 -12.56%
on 11/25/25
+6.90 (+34.09%)
since 12/12/24

Most Recent Stories

More News
Fulgent to Participate in Upcoming Conferences

Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent,” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today...

FLGT : 27.14 (+0.30%)
Fulgent Reports Third Quarter 2025 Financial Results

Revenue of $84.1 million, growing 17% year-over-year Raising Full Year 2025 Revenue Guidance to $325.0 million Raising Full Year 2025 EPS Guidance to GAAP loss of approximately...

FLGT : 27.14 (+0.30%)
Fulgent Shares Preliminary Data from Poster Presentation at ESMO 2025 Conference

Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today...

FLGT : 27.14 (+0.30%)
Fulgent to Announce Third Quarter 2025 Financial Results on Friday, November 7, 2025

Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today...

FLGT : 27.14 (+0.30%)
Fulgent Reports Second Quarter 2025 Financial Results

Core Revenue of $81.7 million grows 16% year-over-year Raising Full Year 2025 Core Revenue Guidance to $320 million GAAP gross profit of...

FLGT : 27.14 (+0.30%)
Fulgent Genetics Receives EU CE Mark for FulgentExome & FulgentPLM

Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent,” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today...

FLGT : 27.14 (+0.30%)
Fulgent Genetics Revenue Tops Estimates

Fulgent Genetics exceeded expectations in the fourth quarter of 2024, showcasing robust revenue growth and a GAAP loss.

FLGT : 27.14 (+0.30%)
Got $2,500? This Dirt Cheap Growth Stock Could Be Worth Buying Hand Over Fist

Fulgent is moving past its pandemic-era business, and that's a good thing.

NVDA : 175.02 (-3.27%)
FLGT : 27.14 (+0.30%)
Better Diversified Biotech Stock: 23andMe vs. Fulgent Genetics

Neither has a traditional business model, but that could be an asset for both.

FLGT : 27.14 (+0.30%)
ME : 0.6063 (-21.26%)
2 Undervalued Stocks to Buy for Potentially Massive Gains in the Next 10 Years

Both are experiencing a bit of a hangover from declining COVID-19-related sales.

FLGT : 27.14 (+0.30%)
PFE : 25.85 (+0.19%)
BNTX : 94.81 (-1.24%)

Business Summary

Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process...

See More

Key Turning Points

3rd Resistance Point 27.83
2nd Resistance Point 27.56
1st Resistance Point 27.35
Last Price 27.14
1st Support Level 26.87
2nd Support Level 26.60
3rd Support Level 26.39

See More

52-Week High 31.04
Last Price 27.14
Fibonacci 61.8% 24.75
Fibonacci 50% 22.81
Fibonacci 38.2% 20.86
52-Week Low 14.57

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar